66 related articles for article (PubMed ID: 1697115)
1. Side effects of FK 506 in cynomolgus monkeys: a histopathologic study.
Tiebosch A; Ericzon BG; Wijnen R; Arends JW; Groth CG; Kootstra G
Transplant Proc; 1990 Aug; 22(4):1652. PubMed ID: 1697115
[No Abstract] [Full Text] [Related]
2. Toxicologic evaluation of FK 506.
Ohara K; Billington R; James RW; Dean GA; Nishiyama M; Noguchi H
Transplant Proc; 1990 Feb; 22(1):83-6. PubMed ID: 1689910
[No Abstract] [Full Text] [Related]
3. Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey.
Ericzon BG; Kubota K; Groth CG; Wijnen R; Tiebosch T; Buurman W; Kootstra G
Transplant Proc; 1990 Feb; 22(1):72-3. PubMed ID: 1689905
[No Abstract] [Full Text] [Related]
4. FK 506-induced nephrotoxicity in rats.
Kumano K; Wang G; Endo T; Kuwao S
Transplant Proc; 1991 Feb; 23(1 Pt 1):512-5. PubMed ID: 1703696
[No Abstract] [Full Text] [Related]
5. Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506.
Ochiai T; Hamaguchi K; Isono K
Transplant Proc; 1987 Oct; 19(5 Suppl 6):93-7. PubMed ID: 2445085
[No Abstract] [Full Text] [Related]
6. Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels.
Wijnen RM; Ericzon BG; Tiebosch AT; Beysens AJ; Groth CG; Kootstra G
Transplant Proc; 1991 Dec; 23(6):3101-4. PubMed ID: 1721371
[No Abstract] [Full Text] [Related]
7. Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimens.
Lee KW; Kim TH; Lee JB; Kim KS; Park JB; Gershkovich P; Yoo SD; Shin S; Shin BS; Kim SJ
J Pharmacol Sci; 2019 Feb; 139(2):65-71. PubMed ID: 30573325
[TBL] [Abstract][Full Text] [Related]
8. Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals.
Ericzon BG; Wijnen RM; Kubota K; Kootstra G; Groth CG
Transplant Proc; 1991 Feb; 23(1 Pt 1):511. PubMed ID: 1703695
[No Abstract] [Full Text] [Related]
9. The influence of FK 506 on the thymus: implications of drug-induced injury to thymic epithelial cells.
Thomson AW; Pugh-Humphreys RG; Woo J
Transplant Proc; 1991 Feb; 23(1 Pt 2):947-8. PubMed ID: 1703361
[No Abstract] [Full Text] [Related]
10. Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokinetics.
Jaffee BD; Jones EA; Zajac I; Magolda RL; Cramer DV; Makowka L
Transplant Proc; 1993 Feb; 25(1 Pt 1):710-1. PubMed ID: 8438449
[No Abstract] [Full Text] [Related]
11. Prolongation of canine renal allograft survival by treatment with FK-506.
Ochiai T; Nagata M; Nakajima K; Sakamoto K; Asano T; Isono K
Transplant Proc; 1987 Oct; 19(5 Suppl 6):53-6. PubMed ID: 2445075
[No Abstract] [Full Text] [Related]
12. Neoral pharmacokinetics in cynomolgus monkeys: relation to efficacy in renal allografting.
Schuurman HJ; Hengy JC; Ringers J; Vonderscher J; Schuler W; Jonker M
Transplant Proc; 1996 Dec; 28(6):3142-4. PubMed ID: 8962218
[No Abstract] [Full Text] [Related]
13. Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.
Flavin T; Ivens K; Wang J; Gutierrez J; Hoyt EG; Billingham M; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):531-2. PubMed ID: 1703701
[No Abstract] [Full Text] [Related]
14. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
Starzl TE; Abu-Elmagd K; Tzakis A; Fung JJ; Porter KA; Todo S
Transplant Proc; 1991 Feb; 23(1 Pt 2):914-9. PubMed ID: 1703351
[TBL] [Abstract][Full Text] [Related]
15. Severe tacrolimus toxicity in rabbits.
Giessler GA; Gades NM; Friedrich PF; Bishop AT
Exp Clin Transplant; 2007 Jun; 5(1):590-5. PubMed ID: 17617048
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells.
Namieno T; Uchino J
Transplant Proc; 1996 Oct; 28(5):2987-90. PubMed ID: 8908147
[No Abstract] [Full Text] [Related]
17. Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study.
Wijnen RM; Ericzon BG; Tiebosch AT; Buurman WA; Groth CG; Kootstra G
Transpl Int; 1992; 5 Suppl 1():S454-8. PubMed ID: 14621844
[TBL] [Abstract][Full Text] [Related]
18. Heterotopic heart transplantation in the rat receiving FK-506.
Lim SM; Thiru S; White DJ
Transplant Proc; 1987 Oct; 19(5 Suppl 6):68-70. PubMed ID: 2445080
[No Abstract] [Full Text] [Related]
19. The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cells.
Epand RF; Epand RM
Anticancer Drug Des; 1991 Jul; 6(3):189-93. PubMed ID: 1714737
[TBL] [Abstract][Full Text] [Related]
20. The side effects of FK 506 in humans.
Shapiro R; Fung JJ; Jain AB; Parks P; Todo S; Starzl TE
Transplant Proc; 1990 Feb; 22(1):35-6. PubMed ID: 1689892
[No Abstract] [Full Text] [Related]
[Next] [New Search]